title: Predialysis chronic kidney disease in 2010: Novel targets for slowing CKD progression.
abstract: Several 2010 trials have provided novel information on how best to manage patients with predialysis chronic kidney disease (CKD). Armed with these new findings, nephrologists can find new means of slowing CKD progression by targeting blood-pressure control, acidosis and serum uric acid levels.
authors.affiliation: Division of Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska University Hospital at Huddinge, Karolinska Institutet, SE 141 86 Stockholm, Sweden.
authors.forename: Juan Jesús
authors.initials: JJ
authors.lastname: Carrero
authors.forename: Peter
authors.initials: P
authors.lastname: Stenvinkel
mesh_terms: D000493:Allopurinol / Q000627:therapeutic use*; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D018450:Disease Progression; D006801:Humans; D051436:Renal Insufficiency, Chronic / Q000188:drug therapy* / Q000503:physiopathology*
chemical_list: D000924:Anticholesteremic Agents; D000959:Antihypertensive Agents; D000493:Allopurinol